← All trials
NCT05251480
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2022
- Primary completion
- Dec 30, 2024
- Completion date
- Dec 1, 2025
- First posted
- Feb 22, 2022
- Last posted
- Jul 28, 2022
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- DeCell Technologies Inc.Lead sponsor
- Lakehead UniversityCollaborator
- Dalhousie UniversityCollaborator
- Dalhousie UniversityOverall official - principal investigator
- Dalhousie UniversityReponsible party - principal investigator
- Canadian Institutes of Health Research (CIHR)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.